ATAGI update following weekly COVID-19 meeting – 9 March 2022

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 9 March 2022.

Date published:
General public

Latest recommendation updates

ATAGI have not made any new updates since 2 March 2022.

Recent ATAGI considerations

On Wednesday 9March 2022, ATAGI met to consider the latest developments relating to COVID-19 immunisation.  As of 8 March 2022, over 54 million doses of COVID-19 vaccines have been administered in Australia. ATAGI encourages anyone aged 16 years and over to receive a booster dose as soon as they are eligible.

Upcoming ATAGI considerations

Evidence relating to second COVID-19 booster doses

ATAGI is continuing to monitor and discuss current and emerging evidence on COVID-19 booster doses, including meeting with international counterparts, reviewing data on effectiveness, waning of immunity and national vaccination coverage as part of broader considerations around potential need for subsequent booster doses, particularly coming into the winter months.

COVID-19 vaccine safety

The TGA Weekly Report provides a detailed breakdown of adverse events following immunisation.

Resources and recent statements

ATAGI recommends review of the following key resources:

More information can be found on the Department of Health website, with resources for both providers and patients.

Help us improve

If you would like a response please use the enquiries form instead.